149 results on '"Nguyen The Anh"'
Search Results
2. Hotspot Immune Exhaustion: Key to Liver Transplant Rejection
3. Sa1498: GASTRIC EMPTYING ABNORMALITIES AND HEALTHCARE UTILIZATION IN PATIENTS WITH MIGRAINE
4. Sa1470: REVISITING THE RISK OF TARDIVE DYSKINESIA WITH METOCLOPRAMIDE USE: A REAL-WORLD DATA DRIVEN EPIDEMIOLOGY STUDY FROM 2011-2021
5. Tu1354: A ZIP CODE-LEVEL ANALYSIS OF ENVIRONMENTAL HAZARD EXPOSURE AND THE INCIDENCE OF IRRITABLE BOWEL SYNDROME AND FUNCTIONAL DYSPEPSIA AMONG COMMERCIALLY INSURED ADULTS IN CALIFORNIA
6. Tu1364: RACE-RELATED COMPARISONS OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION SYMPTOMS, TREATMENT RESPONSE, AND QUALITY OF LIFE: RESULTS OF A POOLED ANALYSIS OF LINACLOTIDE CLINICAL TRIALS
7. Sa1156: MIR-10B-5P PREVENTS DIABETIC GASTROINTESTINAL DYSMOTILITY
8. Tu1336: A REAL-WORLD STUDY OF PERSISTENCE AND ADHERENCE TO PRESCRIPTION MEDICATIONS IN PATIENTS WITH CHRONIC IDIOPATHIC CONSTIPATION
9. Sa1494: BOTULINUM TOXIN INJECTION IMPROVES SYMPTOMS AND GASTRIC EMPTYING AFTER LUNG TRANSPLANTATION BUT DOES NOT AFFECT PULMONARY OUTCOMES: A 19-YEAR RETROSPECTIVE SERIES
10. Tu1733 EFFICACY OF THE ORAL TYROSINE KINASE 2 (TYK2) INHIBITOR TAK-279 IN TWO PRECLINICAL MOUSE MODELS OF COLITIS
11. Su1650 LEUKOCYTOSIS AND HEALTHCARE UTILIZATION IN PATIENTS WITH CANNABIS HYPEREMESIS SYNDROME PRESENTING TO THE EMERGENCY DEPARTMENT
12. 515 IMMUNOMODULATORY EFFECTS OF NON-INVASIVE VAGAL NERVE STIMULATION THERAPY IN IDIOPATHIC GASTROPARESIS
13. Sa415 PELVIC FLOOR DISORDERS IN PATIENTS WITH HYPERMOBILITY SPECTRUM DISORDERS
14. Su1622 PREDICTING RESPONSE TO NEUROMODULATORS OR PROKINETICS IN SUSPECTED GASTROPARESIS USING MACHINE LEARNING MODELS, RESULTS FROM A MULTI-CENTER PROSPECTIVE STUDY
15. 416 THE COLONIC BIOLOGICAL CLOCK AND PREDICTABILITY OF TIME OF BOWEL MOVEMENTS DURING TREATMENT WITH A VIBRATING CAPSULE (VIBRANT®) IN PATIENTS WITH SEVERE CHRONIC IDIOPATHIC CONSTIPATION
16. OrganEx: A Promising Solution for Rescuing Organs After Prolonged Ischemia
17. Su1750 GASTRIC PER-ORAL ENDOSCOPIC PYLOROMYOTOMY (GPOEM) IS A SAFE AND EFFICACIOUS TREATMENT FOR SEVERE REFRACTORY POST LUNG TRANSPLANT GASTROPARESIS: A SINGLE CENTER EXPERIENCE
18. 653 MIR-10B-5P RESCUES AND PREVENTS DIABETIC GASTROPARESIS THROUGH KLF11-KIT PATHWAY
19. Su1756 MEASURES OF GASTROINTESTINAL VAGAL DYSFUNCTION IN GASTROPARESIS PATIENTS
20. Mo1524 PAIN TREATMENT EFFICACY IN PATIENTS WITH FUNCTIONAL AND MOTILITY DISORDERS
21. Tu1752 EFFECT OF LIQUID AND SOLID TEST MEALS ON SYMPTOMS AND GASTRIC MYOELECTRICAL ACTIVITY IN PATIENTS WITH CHRONIC UNEXPLAINED NAUSEA AND VOMITING AND NORMAL GASTRIC EMPTYING VERSUS PATIENTS WITH GASTROPARESIS
22. Su1753 ESTROGEN PROTECTS TYPE 2 DIABETES AND GASTROINTESTINAL SLOW TRANSIT IN FEMALE MICE VIA MIR-10B-5P AND EGR1 PATHWAYS
23. 697 VIRTUAL REALITY MINDFULNESS THERAPY VS. VIRTUAL REALITY DISTRACTIVE THERAPY IN CHRONIC ABDOMINAL PAIN
24. Mo1579 ”I JUST FEEL LIKE AN OUTCAST”: STIGMA EXPERIENCES OF PATIENTS LIVING WITH GASTROPARESIS
25. Su1755 CONSTIPATION IN PATIENTS WITH SYMPTOMS OF GASTROPARESIS: A SEVERE SYMPTOM IN A THIRD OF PATIENTS.
26. Su1754 PREDICTORS OF LONGITUDINAL CHANGES IN SYMPTOM SEVERITY AND QUALITY OF LIFE IN PATIENTS WITH SUSPECTED GASTROPARESIS
27. Mo1592 – Marijuana Use in Patients with Symptoms of Gastroparesis: Prevalence, Patient Characteristics, and Perceived Benefit
28. Tu1614 – Virtual Reality Mindfulness Therapy Reduces Pain and Anxiety in Patients with Chronic Abdominal Pain
29. Tu1185 – Prolonged (96 H) Wireless Ambulatory Esophageal Ph Study in Patients Presenting with Ger Symptoms Under Different Dietary Conditions: A Novel, Practical Concept to Minimize Ppi Use
30. Su1014 – Immune Profiling of the Human Gastric Muocsa in Health and Gastroparesis
31. Su1594 – Reduction in Overall Hospitalizations for Functional and Motility Disroders Between 2005 and 2014: An Analysis of the National Inpatient Sample
32. 429 – Autoimmune Antibodies and Symptoms of Autoimmune Disorder in Gastroparesis Patients
33. Mo1591 – Does Other End-Organ Damage Correlate with Risk of Gastroparesis in Diabetics?
34. Mo1604 – Comparison of Symptom and Quality of Life Outcomes Over 6 Months in Suspected Gastroparesis Due to Diabetic Vs. Nondiabetic Etiology: Importance of Diabetic Subtype and Gastric Emptying Delays
35. Mo1564 – Which Anti-Nausea Therapies Do Patients Believe Work Best? a Patient-Reported Efficacy Study
36. Mo1582 – Transcutaneous Vagal Nerve Stimulation Improves Symptoms and Gastric Emptying in Patients with Idiopathic Gastroparesis
37. Su1446 – Clinical Characteristics of Patients with Symptoms of Gastroparesis and History of Pancreatitis
38. Mo1572 – Delayed Gastric Emptying by Wireless Motility Capsule But Not Scintigraphy is Associated with Worse Symptom Severity Scores
39. Mo1598 – The Diagnosis and Management of Gastroparesis: An International Survey of Motility Experts
40. Sa1549 - Effect of Domperidone on Gastroparesis Symptoms: Analysis of Patients Treated with Domperidone in the Niddk Gastroparesis Clinical Research Consortium (Gpcrc) Registry
41. Sa1578 - Whole Gut Transit and Contractile Abnormalities Captured by Wireless Motility Capsule are Common in Patients with Suspected Gastroparesis Despite Normal Gastric Emptying Scintigraphy
42. Sa1015 - Ethnic and Racial Differences in Gastroparesis: Relationships with Etiology, Symptoms, and Treatment
43. Su1098 - use of Ambulatory Esophageal PH Monitoring to Minimize PPI Utilization in Patients with Gerd Symptoms: A Pilot, Retrospective Cohort Analysis
44. Sa1548 - Abdominal Pain in Gastroparesis: A Severe Symptom in a Third of Gastroparesis Patients
45. 44 - Longitudinal Symptom and Quality of Life Outcomes in Patients with Suspected Gastroparesis in Relation to Delays in Gastric Emptying and Generalized Gut Transit: A Prospective, Multicenter Evaluation
46. Tu1618 - The Integrated Relaxation Pressure may not be an Appropriate Gold Standard for Deglutitive Relaxation Due to Reliance on a Single Intragastric Reference Sensor in the Context of Physiologic Gastric Pressure Heterogeneity
47. Sa1591 - Overlap Between Esophageal and Gastric Dysmotility
48. 143 - Gastric Emptying Changes over Time in Gastroparesis: Comparison of Initial and 48 Week Follow up Gastric Emptying Tests in the Gastroparesis Registry of the Gastroparesis Consortium
49. Aprepitant Has Mixed Effects on Nausea and Reduces Other Symptoms in Patients With Gastroparesis and Related Disorders
50. Vitamin D Deficiency in Gastroparesis and Chronic Unexplained Nausea and Vomiting: Relationship with Gastric Emptying and Symptoms
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.